Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: Investigation of the anti-inflammatory effects of calcitriol

Aisha Rafique*, Anders Etzerodt, Jonas H. Graversen, Søren K. Moestrup, Frederik Dagnæs-Hansen, Holger Jon Møller

*Corresponding author for this work

    Research output: Contribution to journalJournal articleResearchpeer-review

    117 Downloads (Pure)

    Abstract

    Background: Vitamin D3 possesses anti-inflammatory and modulatory properties in addition to its role in calcium and phosphate homeostasis. Upon activation, macrophages (M) can initiate and sustain pro-inflammatory cytokine production in inflammatory disorders and play a pathogenic role in certain cancers. Purpose: The main purpose of this study was to encapsulate and specifically target calcitriol to macrophages and investigate the anti-inflammatory properties of calcitriol in vitro and in vivo. Methods: In this study we have designed and developed near-infrared calcitriol PEGylated nanoparticles (PEG-LNP(Cal)) using a microfluidic mixing technique and modified lipid nanoparticles (LNPs) to target the M specific endocytic receptor CD163. We have investigated LNP cellular uptake and anti-inflammatory effect in LPS-induced M in vitro by flow cytometry, confocal microscopy and gene expression analyses. LNP pharmacodynamics, bio-distribution and organ specific LNP accumulation was also investigated in mice in vivo. Results: In vitro, we observed the specific uptake of PEG-LNP(Cal)-hCD163 in human M, which was significantly higher than the non-specific uptake of control PEG-LNP(Cal)-IgG(h) in M. Pretreatment with encapsulated calcitriol was able to attenuate intracellular TNF-expression, and M surface marker HLA-DR expression more efficiently than free calcitriol in LPS-induced M in vitro. Encapsulated calcitriol diminished mRNA gene levels of TNF-, NF-B, MCP-1 and IL-6, while upregulating IL-10. TNF-and IL-6 protein secretion also decreased. In mice, an in vivo pharmacodynamic study of PEG-LNP(Cal) showed a rapid clearance of IgG and CD163 modified LNPs compared to PEG-LNP(Cal). Antibody modified PEG-LNP(Cal) accumulated in the liver, spleen and kidney, whereas unmodified PEG-LNP(Cal) accumulation was only observed in the liver. Conclusion: Our results show that calcitriol can be effectively targeted to M. Our data confirms the anti-inflammatory properties of calcitriol and this may be a potential way to deliver high dose bioactive calcitriol to M during inflammation in vivo.

    Original languageEnglish
    JournalInternational Journal of Nanomedicine
    Volume14
    Pages (from-to)2829-2846
    ISSN1176-9114
    DOIs
    Publication statusPublished - 23. Apr 2019

    Keywords

    • 1.25(OH)D
    • Calcitriol
    • Cd163 targeted drug delivery
    • Gene expression analyses
    • In vivo pharmacodynamics
    • Lipid nanoparticles
    • Macrophages
    • Pro-inflammatory cytokines

    Fingerprint

    Dive into the research topics of 'Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: Investigation of the anti-inflammatory effects of calcitriol'. Together they form a unique fingerprint.

    Cite this